Memorial Sloan Kettering Cancer Center, New York, NY
Memorial Sloan Kettering Cancer Center, New York, NY.
J Oncol Pract. 2015 Jan;11(1):e81-6. doi: 10.1200/JOP.2014.001487. Epub 2014 Nov 12.
The National Comprehensive Cancer Network (NCCN) palliative care (PC) guideline recommends PC screening for all patients and provides criteria for identifying those in need of referral to a PC specialist. This two-step process has not yet been validated as accurately identifying patients in need. The aim of this study was to validate a simplified method for screening and referral based on the existing guideline criteria.
An 11-item screening tool was created, with scores from 0 to 14. Content validity was assessed by a panel of local PC experts. Construct and criterion validities were evaluated using data obtained from a previous study of guideline-based screening and referral.
Content validity of the tool was high, with eight items rated as essential. Patients who were closer to death had significantly higher scores, indicating its construct validity. Scores were also higher in patients who were identified as needing a consult and in those who had worse pain and other symptoms, indicating its criterion validity. Using a score of ≥ 5 as the trigger, approximately one third of hospitalized patients in the previous study would have been referred to a PC specialist, twice as many as occurred when the attending oncologist relied on his or her clinical judgment.
The tool seems to be a valid method for identifying patients with cancer with complex PC needs who would benefit from a PC consult. Reliability testing, external validation, and demonstration of the utility of the tool as a decision aid all await confirmation.
美国国家综合癌症网络(NCCN)姑息治疗(PC)指南建议对所有患者进行 PC 筛查,并提供了识别需要转介给 PC 专家的患者的标准。这两步流程尚未被验证能准确识别有需求的患者。本研究旨在验证一种基于现有指南标准的简化筛查和转介方法。
创建了一个 11 项的筛查工具,评分范围为 0 至 14 分。通过当地姑息治疗专家小组评估其内容效度。使用基于指南的筛查和转介的先前研究中获得的数据评估其构建和标准效度。
工具的内容效度很高,八项条目被评为必不可少。接近死亡的患者得分明显更高,表明其具有构建效度。在需要咨询的患者和疼痛及其他症状更严重的患者中,得分也更高,表明其具有标准效度。使用≥5 分作为触发点,大约三分之一的先前研究中的住院患者将被转介给 PC 专家,是根据主治肿瘤学家的临床判断进行转介的两倍。
该工具似乎是一种有效方法,可用于识别具有复杂 PC 需求且可能受益于 PC 咨询的癌症患者。还需要进行可靠性测试、外部验证,并证明该工具作为决策辅助工具的实用性。